Silo Pharma, Inc.
SILO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001514183
No open-market purchases or sales by Silo Pharma, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $886.6K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −6 vs. previous quarter
- 9
- 13F valueReported value at the end of Q2 2026
- $886.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SILO, Q2 2026
No superinvestor reported holding SILO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Silo Pharma, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 (view filing)6:34 PM ET | Dec 15 | 1 day | Weisblum EricChief Executive Officer | PPurchase | +5.00K | $0.415 | +$2.08K | +2.4%216.9K after | 2 lots |
| Nov 21, 2025 (view filing)6:35 PM ET | Nov 20-21 | 1 day | Weisblum EricChief Executive Officer | PPurchase | +2.00K | $0.3675 | +$735 | +1.0%211.9K after | 2 lots |
| Nov 20, 2025 (view filing)4:00 PM ET | Nov 18-19 | 2 days | Weisblum EricChief Executive Officer | PPurchase | +12.0K | $0.4039 | +$4.85K | +6.1%209.9K after | 2 lots |
| May 28, 2025 (view filing)4:30 PM ET | May 27 | 1 day | Weisblum EricChief Executive Officer | PPurchase | +10.0K | $0.4329 | +$4.33K | +5.3%197.9K after | |
| Dec 16, 2024 (view filing) | Dec 13 | 3 days | Weisblum EricCEO and President | PPurchase | +2.50K | $0.84 | +$2.10K | +1.3%187.9K after | |
| Nov 22, 2024 (view filing) | Nov 20-22 | 2 days | Weisblum EricCEO and President | PPurchase | +5.00K | $0.925 | +$4.63K | +2.8%185.4K after | 2 lots |
| Jun 13, 2024 (view filing) | Jun 11-12 | 2 days | Weisblum EricCEO and President | PPurchase | +5.00K | $1.11 | +$5.53K | +2.9%180.4K after | 2 lots |
| Apr 8, 2024 (view filing) | Apr 4-5 | 4 days | Weisblum EricCEO and President | PPurchase | +1.00K | $1.99 | +$1.99K | +0.6%175.4K after | 2 lots |
| Apr 1, 2024 (view filing) | Mar 28-Apr 1 | 4 days | Weisblum EricCEO and President | PPurchase | +4.51K | $1.93 | +$8.71K | +2.7%174.4K after | 2 lots |
| Dec 21, 2023 (view filing) | Dec 19-20 | 2 days | Weisblum EricCEO and President | PPurchase | +700 | $1.62 | +$1.14K | +0.4%169.9K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Silo Pharma, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 75,582 | $469.4K | 0.06% | −588,383−88.6% | Reduced |
| FNY Investment Advisers, LLC | 37,507 | $232.0K | 0.08% | +37,507 | New |
| Citadel Advisors LLC | 16,800 | $104.3K | 0.00% | −4,648−21.7% | Reduced |
| Vanguard Capital Management LLC | 11,956 | $74.2K | 0.00% | +735+6.6% | Added |
| Vanguard Fiduciary Trust Co | 874 | $5.43K | 0.00% | −12,226−93.3% | Reduced |
| Tower Research Capital LLC (TRC) | 181 | $1.12K | 0.00% | −1,496−89.2% | Reduced |
| Harbour Investments, Inc. | 14 | $87 | 0.00% | +14 | New |
| IFP Advisors, Inc | 175 | $61 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $6 | 0.00% | 00.0% | Unchanged |